Role of the PKC/CPI-17 pathway in enhanced contractile responses of mesenteric arteries from diabetic rats to α-adrenoceptor stimulation

British Journal of Pharmacology

Volumn 146, Issue 7, 2005, Pages 972-982

  Mueed, Irem ^a   Zhang, Lili ^a   MacLeod, Kathleen M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

adrenoceptor; Contraction; CPI 17; Diabetes; Endothelin 1; G protein coupled receptor; Noradrenaline; PKC; Vascular smooth muscle

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CALPHOSTIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DOWNSTREAM PROCESSING; ENDOTHELIUM CELL; ENZYME INHIBITION; MALE; MESENTERIC ARTERY; NONHUMAN; PARTICULATE MATTER; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIN-1; ISOENZYMES; MALE; MESENTERIC ARTERIES; MUSCLE PROTEINS; NOREPINEPHRINE; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, G-PROTEIN-COUPLED; VASOCONSTRICTION;

EID: 28444491972     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706398     Document Type: Article

References (36)

1. ABEBE, W. & MACLEOD, K.M. (1991). Enhanced arterial contractility to noradrenaline in diabetic rats is associated with increased phosphoinositide metabolism. Can J. Physiol. Pharmacol., 69, 355-361.
2. ABEBE, W. & MACLEOD, K.M. (1992). Augmented inositol phosphate production in mesenteric arteries from diabetic rats. Eur. J. Pharmacol., 225, 29-36.
3. ABEBE, W., HARRIS, K.H. & MACLEOD, K.M. (1990). Enhanced contractile responses of arteries from diabetic rats to a1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J. Cardiovasc. Pharmacol., 16, 239-248.
4. ALTMANN, C., STEENPASS, V., CZYBORRA, P., HEIN, P. & MICHEL, M.C. (2003). Comparison of signalling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine. Br. J. Pharmacol., 138, 261-271.
5. ARIKAWA, E., VERMA, S., DUMONT, A.S. & MCNEILL, J.H. (2001). Chronic bosentan treatment improves renal artery vascular function in diabetes. J. Hypertens., 19, 803-812.
6. CHOW, W.L., ZHANG, L. & MACLEOD, K.M. (2001). Noradrenaline-induced changes in intracellular Ca(2+) and tension in mesenteric arteries from diabetic rats. Br. J. Pharmacol., 134, 179-187.
7. DAVIS, P.D., HILL, C.H., KEECH, E., LAWTON, G., NIXON, J.S., SEDGWICK, A.D., WADSWORTH, J., WESTMACOTT, D. & WILKINSON, S.E. (1989). Potent selective inhibitors of protein kinase C. FEBS Lett., 259, 61-63.
8. ETO, M., KITAZAWA, T., YAZAWA, M., MUKAI, H., ONO, Y. & BRAUTIGAN, D.L. (2001). Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms. J. Biol. Chem., 276, 29072-29078.
9. ETO, M., SENBA, S., MORITA, F. & YAZAWA, M. (1997). Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle. FEBS Lett., 410, 356-360.
10. GUO, M., WU, M.H., KOROMPAI, F. & YUAN, S.Y. (2003). Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes. Physiol. Genomics., 12, 139-146.
11. HARRIS, K.H. & MACLEOD, K.M. (1988). Influence of the endothelium on contractile responses of arteries from diabetic rats. Eur. J. Pharmacol., 153, 55-64.
12. HATTORI, Y., KAWASAKI, H. & KANNO, M. (1999). Increased contractile responses to endothelin-1 and U46619 via a protein kinase C-mediated nifedipine-sensitive pathway in diabetic rat aorta. Res. Commun. Mol. Pathol. Pharmacol., 104, 73-80.
13. INAZU, M., SAKAI, Y. & HOMMA, I. (1991). Contractile responses and calcium mobilization in renal arteries of diabetic rats. Eur. J. Pharmacol., 203, 79-84.
14. INOGUCHI, T., BATTAN, R., HANDLER, E., SPORTSMAN, J.R., HEATH, W. & KING, G.L. (1992). Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc. Natl. Acad. Sci. U.S.A., 89, 11059-11063.
15. INOGUCHI, T., XIA, P., KUNISAKI, M., HIGASHI, S., FEENER, E.P. & KING, G.L. (1994). Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am. J. Physiol., 267, E369-E379.
16. 2 receptor-mediated responses in hindquarters of diabetic rats. Eur. J. Pharmacol., 294, 109-115.
17. KOBAYASHI, E., NAKANO, H., MORIMOTO, M. & TAMAOKI, T. (1989). Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun., 159, 548-553.
18. KOYA, D. & KING, G.L. (1998). Protein kinase C activation and the development of diabetic complications. Diabetes, 47, 859-866.
19. LEE, Y.H., KIM, I., LAPORTE, R., WALSH, M.P. & MORGAN, K.G. (1999). Isozyme-specific inhibitors of protein kinase C translocation: effects on contractility of single permeabilized vascular muscle cells of the ferret. J. Physiol., 517 (Part 3), 709-720.
20. MACLEOD, K.M. (1985). The effect of insulin treatment on changes in vascular reactivity in chronic, experimental diabetes. Diabetes, 34, 1160-1167.
21. MEIER, M. & KING, G.L. (2000). Protein kinase C activation and its pharmacological inhibition in vascular disease. Vasc. Med., 5, 173-185.
22. MOBLEY, PL, HEDBERG, K., BONIN, L., CHEN, B. & GRIFFITH, O.H. (1994). Decreased phosphorylation of four 20-kDa proteins precedes staurosporine- induced disruption of the actin/myosin cytoskeleton in rat astrocytes. Exp. Cell Res., 214, 55-66.
23. OSICKA, T.M., YU, Y., LEE, V., PANAGIOTOPOULOS, S., KEMP, B.E. & JERUMS, G. (2001). Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery. Clin. Sci. (London), 100, 249-257.
24. PING, P., ZHANG, J., QIU, Y., TANG, X.L., MANCHIKALAPUDI, S., CAO, X. & BOLLI, R. (1997). Ischemic pre-conditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ. Res., 81, 404-414.
25. POHL, J., WINDER, S.J., ALLEN, B.G., WALSH, M.P., SELLERS, J.R. & GERTHOFFER, W.T. (1997). Phosphorylation of calponin in airway smooth muscle. Am. J. Physiol., 272, L115-L123.
26. 2+ sensitisation by myosin phosphatase inhibition. J. Physiol., 520 (Part 1), 3.
27. SOHN, U.D., CAO, W., TANG, D.C., STULL, J.T., HAEBERLE, J.R., WANG, C.L., HARNETT, K.M., BEHAR, J. & BIANCANI, P. (2001). Myosin light chain kinase- and PKC-dependent contraction of LES and esophageal smooth muscle. Am. J. Physiol. Gastrointest Liver Physiol., 281, G467-G478.
28. SOKOLOVSKY, M. (1995). Endothelin receptor subtypes and their role in transmembrane signaling mechanisms. Pharmacol. Ther., 68, 435-471.
29. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev., 83, 1325-1358.
30. TAGGART, M.J., LEE, Y.H. & MORGAN, K.G. (1999). Cellular redistribution of PKCalpha, rhoA, and ROKalpha following smooth muscle agonist stimulation. Exp. Cell Res., 251, 92-101.
31. TAYLOR, P.D., OON, B.B., THOMAS, C.R. & POSTON, L. (1994). Prevention by insulin treatment of endothelial dysfunction but not enhanced noradrenaline-induced contractility in mesenteric resistance arteries from streptozotocin-induced diabetic rats. Br. J. Pharmacol., 111, 35-41.
32. TICKERHOOF, M.M., FARRELL, P.A. & KORZICK, D.H. (2003). Alterations in rat coronary vasoreactivity and vascular protein kinase C isoforms in Type 1 diabetes. Am. J. Physiol. Heart Circ. Physiol., 285, H2694-H2703.
33. WEBER, L.P. & MACLEOD, K.M. (1997). Influence of streptozotocin diabetes on the alpha-1 adrenoceptor and associated G proteins in rat arteries. J. Pharmacol. Exp. Ther., 283, 1469-1478.
34. WIGG, S.J., TARE, M., FORBES, I., COOPER, M.E., THOMAS, M.C., COLEMAN, H.A., PARKINGTON, H.C. & O'BRIEN, R.C. (2004). Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats. Diabetologia, 47, 1038-1046.
35. 2+ sensitivity of protein kinase C-induced contraction in rabbit smooth muscle. J. Physiol., 535, 553-564.
36. ZEMLICKOVA, E., JOHANNES, F.J., AITKEN, A. & DUBOIS, T. (2004). Association of CPI-17 with protein kinase C and casein kinase I. Biochem. Biophys. Res. Commun., 316, 39-47.